Global Hemostatic Agents in Endoscopy Market Growth 2026-2032
The global Hemostatic Agents in Endoscopy market size is predicted to grow from US$ 235 million in 2025 to US$ 435 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.
Hemostatic agents in endoscopy are topical materials delivered through an endoscope to stop or reduce bleeding inside the gastrointestinal tract during diagnostic or therapeutic endoscopic procedures.
They are different from mechanical or thermal hemostasis devices such as clips, coagulation forceps, APC probes, or electrosurgical knives. Hemostatic agents are usually applied as a gel, spray, powder, liquid, or sealant directly onto the bleeding site or post-resection wound surface.
In 2025, global hemostatic agents in endoscopy sales volume reached approximately 163 k units, with an average price of approximately US$ 1480 per unit.
United States market for Hemostatic Agents in Endoscopy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Hemostatic Agents in Endoscopy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Hemostatic Agents in Endoscopy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Hemostatic Agents in Endoscopy players cover 3-D Matrix, Cook Medical, Medtronic, EndoClot Plus, Ankaferd Health Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Hemostatic Agents in Endoscopy Industry Forecast? looks at past sales and reviews total world Hemostatic Agents in Endoscopy sales in 2025, providing a comprehensive analysis by region and market sector of projected Hemostatic Agents in Endoscopy sales for 2026 through 2032. With Hemostatic Agents in Endoscopy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostatic Agents in Endoscopy industry.
This Insight Report provides a comprehensive analysis of the global Hemostatic Agents in Endoscopy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostatic Agents in Endoscopy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Hemostatic Agents in Endoscopy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostatic Agents in Endoscopy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostatic Agents in Endoscopy.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostatic Agents in Endoscopy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Hemostatic Agents in Endoscopy market?
What factors are driving Hemostatic Agents in Endoscopy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemostatic Agents in Endoscopy market opportunities vary by end market size?
How does Hemostatic Agents in Endoscopy break out by Type, by Application?
Hemostatic agents in endoscopy are topical materials delivered through an endoscope to stop or reduce bleeding inside the gastrointestinal tract during diagnostic or therapeutic endoscopic procedures.
They are different from mechanical or thermal hemostasis devices such as clips, coagulation forceps, APC probes, or electrosurgical knives. Hemostatic agents are usually applied as a gel, spray, powder, liquid, or sealant directly onto the bleeding site or post-resection wound surface.
In 2025, global hemostatic agents in endoscopy sales volume reached approximately 163 k units, with an average price of approximately US$ 1480 per unit.
United States market for Hemostatic Agents in Endoscopy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Hemostatic Agents in Endoscopy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Hemostatic Agents in Endoscopy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Hemostatic Agents in Endoscopy players cover 3-D Matrix, Cook Medical, Medtronic, EndoClot Plus, Ankaferd Health Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Hemostatic Agents in Endoscopy Industry Forecast? looks at past sales and reviews total world Hemostatic Agents in Endoscopy sales in 2025, providing a comprehensive analysis by region and market sector of projected Hemostatic Agents in Endoscopy sales for 2026 through 2032. With Hemostatic Agents in Endoscopy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostatic Agents in Endoscopy industry.
This Insight Report provides a comprehensive analysis of the global Hemostatic Agents in Endoscopy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostatic Agents in Endoscopy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Hemostatic Agents in Endoscopy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostatic Agents in Endoscopy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostatic Agents in Endoscopy.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostatic Agents in Endoscopy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Peptide Hydrogels
- Mineral Hemostatic Powder
- Other
- Self-assembling Type
- Spray Type
- Other
- ESD
- EMR
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- 3-D Matrix
- Cook Medical
- Medtronic
- EndoClot Plus
- Ankaferd Health Products
What is the 10-year outlook for the global Hemostatic Agents in Endoscopy market?
What factors are driving Hemostatic Agents in Endoscopy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemostatic Agents in Endoscopy market opportunities vary by end market size?
How does Hemostatic Agents in Endoscopy break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemostatic Agents in Endoscopy Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Hemostatic Agents in Endoscopy by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Hemostatic Agents in Endoscopy by Country/Region, 2021, 2025 & 2032
2.2 Hemostatic Agents in Endoscopy Segment by Type
2.2.1 Peptide Hydrogels
2.2.2 Mineral Hemostatic Powder
2.2.3 Other
2.2.4 Hemostatic Agents in Endoscopy Sales by Type
2.2.4.1 Global Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
2.2.4.2 Global Hemostatic Agents in Endoscopy Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Hemostatic Agents in Endoscopy Sale Price by Type (2021-2026)
2.3 Hemostatic Agents in Endoscopy Segment by Product
2.3.1 Self-assembling Type
2.3.2 Spray Type
2.3.3 Other
2.3.4 Hemostatic Agents in Endoscopy Sales by Product
2.3.4.1 Global Hemostatic Agents in Endoscopy Sales Market Share by Product (2021-2026)
2.3.4.2 Global Hemostatic Agents in Endoscopy Revenue and Market Share by Product (2021-2026)
2.3.4.3 Global Hemostatic Agents in Endoscopy Sale Price by Product (2021-2026)
2.4 Hemostatic Agents in Endoscopy Segment by Application
2.4.1 ESD
2.4.2 EMR
2.4.3 Other
2.4.4 Hemostatic Agents in Endoscopy Sales by Application
2.4.4.1 Global Hemostatic Agents in Endoscopy Sale Market Share by Application (2021-2026)
2.4.4.2 Global Hemostatic Agents in Endoscopy Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Hemostatic Agents in Endoscopy Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Hemostatic Agents in Endoscopy Breakdown Data by Company
3.1.1 Global Hemostatic Agents in Endoscopy Annual Sales by Company (2021-2026)
3.1.2 Global Hemostatic Agents in Endoscopy Sales Market Share by Company (2021-2026)
3.2 Global Hemostatic Agents in Endoscopy Annual Revenue by Company (2021-2026)
3.2.1 Global Hemostatic Agents in Endoscopy Revenue by Company (2021-2026)
3.2.2 Global Hemostatic Agents in Endoscopy Revenue Market Share by Company (2021-2026)
3.3 Global Hemostatic Agents in Endoscopy Sale Price by Company
3.4 Key Manufacturers Hemostatic Agents in Endoscopy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemostatic Agents in Endoscopy Product Location Distribution
3.4.2 Players Hemostatic Agents in Endoscopy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEMOSTATIC AGENTS IN ENDOSCOPY BY GEOGRAPHIC REGION
4.1 World Historic Hemostatic Agents in Endoscopy Market Size by Geographic Region (2021-2026)
4.1.1 Global Hemostatic Agents in Endoscopy Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Hemostatic Agents in Endoscopy Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Hemostatic Agents in Endoscopy Market Size by Country/Region (2021-2026)
4.2.1 Global Hemostatic Agents in Endoscopy Annual Sales by Country/Region (2021-2026)
4.2.2 Global Hemostatic Agents in Endoscopy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hemostatic Agents in Endoscopy Sales Growth
4.4 APAC Hemostatic Agents in Endoscopy Sales Growth
4.5 Europe Hemostatic Agents in Endoscopy Sales Growth
4.6 Middle East & Africa Hemostatic Agents in Endoscopy Sales Growth
5 AMERICAS
5.1 Americas Hemostatic Agents in Endoscopy Sales by Country
5.1.1 Americas Hemostatic Agents in Endoscopy Sales by Country (2021-2026)
5.1.2 Americas Hemostatic Agents in Endoscopy Revenue by Country (2021-2026)
5.2 Americas Hemostatic Agents in Endoscopy Sales by Type (2021-2026)
5.3 Americas Hemostatic Agents in Endoscopy Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemostatic Agents in Endoscopy Sales by Region
6.1.1 APAC Hemostatic Agents in Endoscopy Sales by Region (2021-2026)
6.1.2 APAC Hemostatic Agents in Endoscopy Revenue by Region (2021-2026)
6.2 APAC Hemostatic Agents in Endoscopy Sales by Type (2021-2026)
6.3 APAC Hemostatic Agents in Endoscopy Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemostatic Agents in Endoscopy by Country
7.1.1 Europe Hemostatic Agents in Endoscopy Sales by Country (2021-2026)
7.1.2 Europe Hemostatic Agents in Endoscopy Revenue by Country (2021-2026)
7.2 Europe Hemostatic Agents in Endoscopy Sales by Type (2021-2026)
7.3 Europe Hemostatic Agents in Endoscopy Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemostatic Agents in Endoscopy by Country
8.1.1 Middle East & Africa Hemostatic Agents in Endoscopy Sales by Country (2021-2026)
8.1.2 Middle East & Africa Hemostatic Agents in Endoscopy Revenue by Country (2021-2026)
8.2 Middle East & Africa Hemostatic Agents in Endoscopy Sales by Type (2021-2026)
8.3 Middle East & Africa Hemostatic Agents in Endoscopy Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemostatic Agents in Endoscopy
10.3 Manufacturing Process Analysis of Hemostatic Agents in Endoscopy
10.4 Industry Chain Structure of Hemostatic Agents in Endoscopy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemostatic Agents in Endoscopy Distributors
11.3 Hemostatic Agents in Endoscopy Customer
12 WORLD FORECAST REVIEW FOR HEMOSTATIC AGENTS IN ENDOSCOPY BY GEOGRAPHIC REGION
12.1 Global Hemostatic Agents in Endoscopy Market Size Forecast by Region
12.1.1 Global Hemostatic Agents in Endoscopy Forecast by Region (2027-2032)
12.1.2 Global Hemostatic Agents in Endoscopy Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Hemostatic Agents in Endoscopy Forecast by Type (2027-2032)
12.7 Global Hemostatic Agents in Endoscopy Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 3-D Matrix
13.1.1 3-D Matrix Company Information
13.1.2 3-D Matrix Hemostatic Agents in Endoscopy Product Portfolios and Specifications
13.1.3 3-D Matrix Hemostatic Agents in Endoscopy Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 3-D Matrix Main Business Overview
13.1.5 3-D Matrix Latest Developments
13.2 Cook Medical
13.2.1 Cook Medical Company Information
13.2.2 Cook Medical Hemostatic Agents in Endoscopy Product Portfolios and Specifications
13.2.3 Cook Medical Hemostatic Agents in Endoscopy Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Cook Medical Main Business Overview
13.2.5 Cook Medical Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Hemostatic Agents in Endoscopy Product Portfolios and Specifications
13.3.3 Medtronic Hemostatic Agents in Endoscopy Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 EndoClot Plus
13.4.1 EndoClot Plus Company Information
13.4.2 EndoClot Plus Hemostatic Agents in Endoscopy Product Portfolios and Specifications
13.4.3 EndoClot Plus Hemostatic Agents in Endoscopy Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 EndoClot Plus Main Business Overview
13.4.5 EndoClot Plus Latest Developments
13.5 Ankaferd Health Products
13.5.1 Ankaferd Health Products Company Information
13.5.2 Ankaferd Health Products Hemostatic Agents in Endoscopy Product Portfolios and Specifications
13.5.3 Ankaferd Health Products Hemostatic Agents in Endoscopy Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ankaferd Health Products Main Business Overview
13.5.5 Ankaferd Health Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemostatic Agents in Endoscopy Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Hemostatic Agents in Endoscopy by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Hemostatic Agents in Endoscopy by Country/Region, 2021, 2025 & 2032
2.2 Hemostatic Agents in Endoscopy Segment by Type
2.2.1 Peptide Hydrogels
2.2.2 Mineral Hemostatic Powder
2.2.3 Other
2.2.4 Hemostatic Agents in Endoscopy Sales by Type
2.2.4.1 Global Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
2.2.4.2 Global Hemostatic Agents in Endoscopy Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Hemostatic Agents in Endoscopy Sale Price by Type (2021-2026)
2.3 Hemostatic Agents in Endoscopy Segment by Product
2.3.1 Self-assembling Type
2.3.2 Spray Type
2.3.3 Other
2.3.4 Hemostatic Agents in Endoscopy Sales by Product
2.3.4.1 Global Hemostatic Agents in Endoscopy Sales Market Share by Product (2021-2026)
2.3.4.2 Global Hemostatic Agents in Endoscopy Revenue and Market Share by Product (2021-2026)
2.3.4.3 Global Hemostatic Agents in Endoscopy Sale Price by Product (2021-2026)
2.4 Hemostatic Agents in Endoscopy Segment by Application
2.4.1 ESD
2.4.2 EMR
2.4.3 Other
2.4.4 Hemostatic Agents in Endoscopy Sales by Application
2.4.4.1 Global Hemostatic Agents in Endoscopy Sale Market Share by Application (2021-2026)
2.4.4.2 Global Hemostatic Agents in Endoscopy Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Hemostatic Agents in Endoscopy Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Hemostatic Agents in Endoscopy Breakdown Data by Company
3.1.1 Global Hemostatic Agents in Endoscopy Annual Sales by Company (2021-2026)
3.1.2 Global Hemostatic Agents in Endoscopy Sales Market Share by Company (2021-2026)
3.2 Global Hemostatic Agents in Endoscopy Annual Revenue by Company (2021-2026)
3.2.1 Global Hemostatic Agents in Endoscopy Revenue by Company (2021-2026)
3.2.2 Global Hemostatic Agents in Endoscopy Revenue Market Share by Company (2021-2026)
3.3 Global Hemostatic Agents in Endoscopy Sale Price by Company
3.4 Key Manufacturers Hemostatic Agents in Endoscopy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemostatic Agents in Endoscopy Product Location Distribution
3.4.2 Players Hemostatic Agents in Endoscopy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEMOSTATIC AGENTS IN ENDOSCOPY BY GEOGRAPHIC REGION
4.1 World Historic Hemostatic Agents in Endoscopy Market Size by Geographic Region (2021-2026)
4.1.1 Global Hemostatic Agents in Endoscopy Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Hemostatic Agents in Endoscopy Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Hemostatic Agents in Endoscopy Market Size by Country/Region (2021-2026)
4.2.1 Global Hemostatic Agents in Endoscopy Annual Sales by Country/Region (2021-2026)
4.2.2 Global Hemostatic Agents in Endoscopy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hemostatic Agents in Endoscopy Sales Growth
4.4 APAC Hemostatic Agents in Endoscopy Sales Growth
4.5 Europe Hemostatic Agents in Endoscopy Sales Growth
4.6 Middle East & Africa Hemostatic Agents in Endoscopy Sales Growth
5 AMERICAS
5.1 Americas Hemostatic Agents in Endoscopy Sales by Country
5.1.1 Americas Hemostatic Agents in Endoscopy Sales by Country (2021-2026)
5.1.2 Americas Hemostatic Agents in Endoscopy Revenue by Country (2021-2026)
5.2 Americas Hemostatic Agents in Endoscopy Sales by Type (2021-2026)
5.3 Americas Hemostatic Agents in Endoscopy Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemostatic Agents in Endoscopy Sales by Region
6.1.1 APAC Hemostatic Agents in Endoscopy Sales by Region (2021-2026)
6.1.2 APAC Hemostatic Agents in Endoscopy Revenue by Region (2021-2026)
6.2 APAC Hemostatic Agents in Endoscopy Sales by Type (2021-2026)
6.3 APAC Hemostatic Agents in Endoscopy Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemostatic Agents in Endoscopy by Country
7.1.1 Europe Hemostatic Agents in Endoscopy Sales by Country (2021-2026)
7.1.2 Europe Hemostatic Agents in Endoscopy Revenue by Country (2021-2026)
7.2 Europe Hemostatic Agents in Endoscopy Sales by Type (2021-2026)
7.3 Europe Hemostatic Agents in Endoscopy Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemostatic Agents in Endoscopy by Country
8.1.1 Middle East & Africa Hemostatic Agents in Endoscopy Sales by Country (2021-2026)
8.1.2 Middle East & Africa Hemostatic Agents in Endoscopy Revenue by Country (2021-2026)
8.2 Middle East & Africa Hemostatic Agents in Endoscopy Sales by Type (2021-2026)
8.3 Middle East & Africa Hemostatic Agents in Endoscopy Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemostatic Agents in Endoscopy
10.3 Manufacturing Process Analysis of Hemostatic Agents in Endoscopy
10.4 Industry Chain Structure of Hemostatic Agents in Endoscopy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemostatic Agents in Endoscopy Distributors
11.3 Hemostatic Agents in Endoscopy Customer
12 WORLD FORECAST REVIEW FOR HEMOSTATIC AGENTS IN ENDOSCOPY BY GEOGRAPHIC REGION
12.1 Global Hemostatic Agents in Endoscopy Market Size Forecast by Region
12.1.1 Global Hemostatic Agents in Endoscopy Forecast by Region (2027-2032)
12.1.2 Global Hemostatic Agents in Endoscopy Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Hemostatic Agents in Endoscopy Forecast by Type (2027-2032)
12.7 Global Hemostatic Agents in Endoscopy Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 3-D Matrix
13.1.1 3-D Matrix Company Information
13.1.2 3-D Matrix Hemostatic Agents in Endoscopy Product Portfolios and Specifications
13.1.3 3-D Matrix Hemostatic Agents in Endoscopy Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 3-D Matrix Main Business Overview
13.1.5 3-D Matrix Latest Developments
13.2 Cook Medical
13.2.1 Cook Medical Company Information
13.2.2 Cook Medical Hemostatic Agents in Endoscopy Product Portfolios and Specifications
13.2.3 Cook Medical Hemostatic Agents in Endoscopy Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Cook Medical Main Business Overview
13.2.5 Cook Medical Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Hemostatic Agents in Endoscopy Product Portfolios and Specifications
13.3.3 Medtronic Hemostatic Agents in Endoscopy Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 EndoClot Plus
13.4.1 EndoClot Plus Company Information
13.4.2 EndoClot Plus Hemostatic Agents in Endoscopy Product Portfolios and Specifications
13.4.3 EndoClot Plus Hemostatic Agents in Endoscopy Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 EndoClot Plus Main Business Overview
13.4.5 EndoClot Plus Latest Developments
13.5 Ankaferd Health Products
13.5.1 Ankaferd Health Products Company Information
13.5.2 Ankaferd Health Products Hemostatic Agents in Endoscopy Product Portfolios and Specifications
13.5.3 Ankaferd Health Products Hemostatic Agents in Endoscopy Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ankaferd Health Products Main Business Overview
13.5.5 Ankaferd Health Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hemostatic Agents in Endoscopy Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Hemostatic Agents in Endoscopy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peptide Hydrogels
Table 4. Major Players of Mineral Hemostatic Powder
Table 5. Major Players of Other
Table 6. Global Hemostatic Agents in Endoscopy Sales by Type (2021-2026) & (K Units)
Table 7. Global Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
Table 8. Global Hemostatic Agents in Endoscopy Revenue by Type (2021-2026) & ($ million)
Table 9. Global Hemostatic Agents in Endoscopy Revenue Market Share by Type (2021-2026)
Table 10. Global Hemostatic Agents in Endoscopy Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Self-assembling Type
Table 12. Major Players of Spray Type
Table 13. Major Players of Other
Table 14. Global Hemostatic Agents in Endoscopy Sales by Product (2021-2026) & (K Units)
Table 15. Global Hemostatic Agents in Endoscopy Sales Market Share by Product (2021-2026)
Table 16. Global Hemostatic Agents in Endoscopy Revenue by Product (2021-2026) & ($ million)
Table 17. Global Hemostatic Agents in Endoscopy Revenue Market Share by Product (2021-2026)
Table 18. Global Hemostatic Agents in Endoscopy Sale Price by Product (2021-2026) & (US$/Unit)
Table 19. Global Hemostatic Agents in Endoscopy Sale by Application (2021-2026) & (K Units)
Table 20. Global Hemostatic Agents in Endoscopy Sale Market Share by Application (2021-2026)
Table 21. Global Hemostatic Agents in Endoscopy Revenue by Application (2021-2026) & ($ million)
Table 22. Global Hemostatic Agents in Endoscopy Revenue Market Share by Application (2021-2026)
Table 23. Global Hemostatic Agents in Endoscopy Sale Price by Application (2021-2026) & (US$/Unit)
Table 24. Global Hemostatic Agents in Endoscopy Sales by Company (2021-2026) & (K Units)
Table 25. Global Hemostatic Agents in Endoscopy Sales Market Share by Company (2021-2026)
Table 26. Global Hemostatic Agents in Endoscopy Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Hemostatic Agents in Endoscopy Revenue Market Share by Company (2021-2026)
Table 28. Global Hemostatic Agents in Endoscopy Sale Price by Company (2021-2026) & (US$/Unit)
Table 29. Key Manufacturers Hemostatic Agents in Endoscopy Producing Area Distribution and Sales Area
Table 30. Players Hemostatic Agents in Endoscopy Products Offered
Table 31. Hemostatic Agents in Endoscopy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Hemostatic Agents in Endoscopy Sales by Geographic Region (2021-2026) & (K Units)
Table 35. Global Hemostatic Agents in Endoscopy Sales Market Share Geographic Region (2021-2026)
Table 36. Global Hemostatic Agents in Endoscopy Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Hemostatic Agents in Endoscopy Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Hemostatic Agents in Endoscopy Sales by Country/Region (2021-2026) & (K Units)
Table 39. Global Hemostatic Agents in Endoscopy Sales Market Share by Country/Region (2021-2026)
Table 40. Global Hemostatic Agents in Endoscopy Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Hemostatic Agents in Endoscopy Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Hemostatic Agents in Endoscopy Sales by Country (2021-2026) & (K Units)
Table 43. Americas Hemostatic Agents in Endoscopy Sales Market Share by Country (2021-2026)
Table 44. Americas Hemostatic Agents in Endoscopy Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Hemostatic Agents in Endoscopy Sales by Type (2021-2026) & (K Units)
Table 46. Americas Hemostatic Agents in Endoscopy Sales by Application (2021-2026) & (K Units)
Table 47. APAC Hemostatic Agents in Endoscopy Sales by Region (2021-2026) & (K Units)
Table 48. APAC Hemostatic Agents in Endoscopy Sales Market Share by Region (2021-2026)
Table 49. APAC Hemostatic Agents in Endoscopy Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Hemostatic Agents in Endoscopy Sales by Type (2021-2026) & (K Units)
Table 51. APAC Hemostatic Agents in Endoscopy Sales by Application (2021-2026) & (K Units)
Table 52. Europe Hemostatic Agents in Endoscopy Sales by Country (2021-2026) & (K Units)
Table 53. Europe Hemostatic Agents in Endoscopy Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Hemostatic Agents in Endoscopy Sales by Type (2021-2026) & (K Units)
Table 55. Europe Hemostatic Agents in Endoscopy Sales by Application (2021-2026) & (K Units)
Table 56. Middle East & Africa Hemostatic Agents in Endoscopy Sales by Country (2021-2026) & (K Units)
Table 57. Middle East & Africa Hemostatic Agents in Endoscopy Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Hemostatic Agents in Endoscopy Sales by Type (2021-2026) & (K Units)
Table 59. Middle East & Africa Hemostatic Agents in Endoscopy Sales by Application (2021-2026) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Hemostatic Agents in Endoscopy
Table 61. Key Market Challenges & Risks of Hemostatic Agents in Endoscopy
Table 62. Key Industry Trends of Hemostatic Agents in Endoscopy
Table 63. Hemostatic Agents in Endoscopy Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Hemostatic Agents in Endoscopy Distributors List
Table 66. Hemostatic Agents in Endoscopy Customer List
Table 67. Global Hemostatic Agents in Endoscopy Sales Forecast by Region (2027-2032) & (K Units)
Table 68. Global Hemostatic Agents in Endoscopy Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Hemostatic Agents in Endoscopy Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Americas Hemostatic Agents in Endoscopy Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Hemostatic Agents in Endoscopy Sales Forecast by Region (2027-2032) & (K Units)
Table 72. APAC Hemostatic Agents in Endoscopy Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Hemostatic Agents in Endoscopy Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Europe Hemostatic Agents in Endoscopy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Hemostatic Agents in Endoscopy Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Middle East & Africa Hemostatic Agents in Endoscopy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Hemostatic Agents in Endoscopy Sales Forecast by Type (2027-2032) & (K Units)
Table 78. Global Hemostatic Agents in Endoscopy Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Hemostatic Agents in Endoscopy Sales Forecast by Application (2027-2032) & (K Units)
Table 80. Global Hemostatic Agents in Endoscopy Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. 3-D Matrix Basic Information, Hemostatic Agents in Endoscopy Manufacturing Base, Sales Area and Its Competitors
Table 82. 3-D Matrix Hemostatic Agents in Endoscopy Product Portfolios and Specifications
Table 83. 3-D Matrix Hemostatic Agents in Endoscopy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. 3-D Matrix Main Business
Table 85. 3-D Matrix Latest Developments
Table 86. Cook Medical Basic Information, Hemostatic Agents in Endoscopy Manufacturing Base, Sales Area and Its Competitors
Table 87. Cook Medical Hemostatic Agents in Endoscopy Product Portfolios and Specifications
Table 88. Cook Medical Hemostatic Agents in Endoscopy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Cook Medical Main Business
Table 90. Cook Medical Latest Developments
Table 91. Medtronic Basic Information, Hemostatic Agents in Endoscopy Manufacturing Base, Sales Area and Its Competitors
Table 92. Medtronic Hemostatic Agents in Endoscopy Product Portfolios and Specifications
Table 93. Medtronic Hemostatic Agents in Endoscopy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Medtronic Main Business
Table 95. Medtronic Latest Developments
Table 96. EndoClot Plus Basic Information, Hemostatic Agents in Endoscopy Manufacturing Base, Sales Area and Its Competitors
Table 97. EndoClot Plus Hemostatic Agents in Endoscopy Product Portfolios and Specifications
Table 98. EndoClot Plus Hemostatic Agents in Endoscopy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. EndoClot Plus Main Business
Table 100. EndoClot Plus Latest Developments
Table 101. Ankaferd Health Products Basic Information, Hemostatic Agents in Endoscopy Manufacturing Base, Sales Area and Its Competitors
Table 102. Ankaferd Health Products Hemostatic Agents in Endoscopy Product Portfolios and Specifications
Table 103. Ankaferd Health Products Hemostatic Agents in Endoscopy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Ankaferd Health Products Main Business
Table 105. Ankaferd Health Products Latest Developments
Table 1. Hemostatic Agents in Endoscopy Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Hemostatic Agents in Endoscopy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peptide Hydrogels
Table 4. Major Players of Mineral Hemostatic Powder
Table 5. Major Players of Other
Table 6. Global Hemostatic Agents in Endoscopy Sales by Type (2021-2026) & (K Units)
Table 7. Global Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
Table 8. Global Hemostatic Agents in Endoscopy Revenue by Type (2021-2026) & ($ million)
Table 9. Global Hemostatic Agents in Endoscopy Revenue Market Share by Type (2021-2026)
Table 10. Global Hemostatic Agents in Endoscopy Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Self-assembling Type
Table 12. Major Players of Spray Type
Table 13. Major Players of Other
Table 14. Global Hemostatic Agents in Endoscopy Sales by Product (2021-2026) & (K Units)
Table 15. Global Hemostatic Agents in Endoscopy Sales Market Share by Product (2021-2026)
Table 16. Global Hemostatic Agents in Endoscopy Revenue by Product (2021-2026) & ($ million)
Table 17. Global Hemostatic Agents in Endoscopy Revenue Market Share by Product (2021-2026)
Table 18. Global Hemostatic Agents in Endoscopy Sale Price by Product (2021-2026) & (US$/Unit)
Table 19. Global Hemostatic Agents in Endoscopy Sale by Application (2021-2026) & (K Units)
Table 20. Global Hemostatic Agents in Endoscopy Sale Market Share by Application (2021-2026)
Table 21. Global Hemostatic Agents in Endoscopy Revenue by Application (2021-2026) & ($ million)
Table 22. Global Hemostatic Agents in Endoscopy Revenue Market Share by Application (2021-2026)
Table 23. Global Hemostatic Agents in Endoscopy Sale Price by Application (2021-2026) & (US$/Unit)
Table 24. Global Hemostatic Agents in Endoscopy Sales by Company (2021-2026) & (K Units)
Table 25. Global Hemostatic Agents in Endoscopy Sales Market Share by Company (2021-2026)
Table 26. Global Hemostatic Agents in Endoscopy Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Hemostatic Agents in Endoscopy Revenue Market Share by Company (2021-2026)
Table 28. Global Hemostatic Agents in Endoscopy Sale Price by Company (2021-2026) & (US$/Unit)
Table 29. Key Manufacturers Hemostatic Agents in Endoscopy Producing Area Distribution and Sales Area
Table 30. Players Hemostatic Agents in Endoscopy Products Offered
Table 31. Hemostatic Agents in Endoscopy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Hemostatic Agents in Endoscopy Sales by Geographic Region (2021-2026) & (K Units)
Table 35. Global Hemostatic Agents in Endoscopy Sales Market Share Geographic Region (2021-2026)
Table 36. Global Hemostatic Agents in Endoscopy Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Hemostatic Agents in Endoscopy Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Hemostatic Agents in Endoscopy Sales by Country/Region (2021-2026) & (K Units)
Table 39. Global Hemostatic Agents in Endoscopy Sales Market Share by Country/Region (2021-2026)
Table 40. Global Hemostatic Agents in Endoscopy Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Hemostatic Agents in Endoscopy Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Hemostatic Agents in Endoscopy Sales by Country (2021-2026) & (K Units)
Table 43. Americas Hemostatic Agents in Endoscopy Sales Market Share by Country (2021-2026)
Table 44. Americas Hemostatic Agents in Endoscopy Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Hemostatic Agents in Endoscopy Sales by Type (2021-2026) & (K Units)
Table 46. Americas Hemostatic Agents in Endoscopy Sales by Application (2021-2026) & (K Units)
Table 47. APAC Hemostatic Agents in Endoscopy Sales by Region (2021-2026) & (K Units)
Table 48. APAC Hemostatic Agents in Endoscopy Sales Market Share by Region (2021-2026)
Table 49. APAC Hemostatic Agents in Endoscopy Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Hemostatic Agents in Endoscopy Sales by Type (2021-2026) & (K Units)
Table 51. APAC Hemostatic Agents in Endoscopy Sales by Application (2021-2026) & (K Units)
Table 52. Europe Hemostatic Agents in Endoscopy Sales by Country (2021-2026) & (K Units)
Table 53. Europe Hemostatic Agents in Endoscopy Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Hemostatic Agents in Endoscopy Sales by Type (2021-2026) & (K Units)
Table 55. Europe Hemostatic Agents in Endoscopy Sales by Application (2021-2026) & (K Units)
Table 56. Middle East & Africa Hemostatic Agents in Endoscopy Sales by Country (2021-2026) & (K Units)
Table 57. Middle East & Africa Hemostatic Agents in Endoscopy Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Hemostatic Agents in Endoscopy Sales by Type (2021-2026) & (K Units)
Table 59. Middle East & Africa Hemostatic Agents in Endoscopy Sales by Application (2021-2026) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Hemostatic Agents in Endoscopy
Table 61. Key Market Challenges & Risks of Hemostatic Agents in Endoscopy
Table 62. Key Industry Trends of Hemostatic Agents in Endoscopy
Table 63. Hemostatic Agents in Endoscopy Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Hemostatic Agents in Endoscopy Distributors List
Table 66. Hemostatic Agents in Endoscopy Customer List
Table 67. Global Hemostatic Agents in Endoscopy Sales Forecast by Region (2027-2032) & (K Units)
Table 68. Global Hemostatic Agents in Endoscopy Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Hemostatic Agents in Endoscopy Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Americas Hemostatic Agents in Endoscopy Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Hemostatic Agents in Endoscopy Sales Forecast by Region (2027-2032) & (K Units)
Table 72. APAC Hemostatic Agents in Endoscopy Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Hemostatic Agents in Endoscopy Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Europe Hemostatic Agents in Endoscopy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Hemostatic Agents in Endoscopy Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Middle East & Africa Hemostatic Agents in Endoscopy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Hemostatic Agents in Endoscopy Sales Forecast by Type (2027-2032) & (K Units)
Table 78. Global Hemostatic Agents in Endoscopy Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Hemostatic Agents in Endoscopy Sales Forecast by Application (2027-2032) & (K Units)
Table 80. Global Hemostatic Agents in Endoscopy Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. 3-D Matrix Basic Information, Hemostatic Agents in Endoscopy Manufacturing Base, Sales Area and Its Competitors
Table 82. 3-D Matrix Hemostatic Agents in Endoscopy Product Portfolios and Specifications
Table 83. 3-D Matrix Hemostatic Agents in Endoscopy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. 3-D Matrix Main Business
Table 85. 3-D Matrix Latest Developments
Table 86. Cook Medical Basic Information, Hemostatic Agents in Endoscopy Manufacturing Base, Sales Area and Its Competitors
Table 87. Cook Medical Hemostatic Agents in Endoscopy Product Portfolios and Specifications
Table 88. Cook Medical Hemostatic Agents in Endoscopy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Cook Medical Main Business
Table 90. Cook Medical Latest Developments
Table 91. Medtronic Basic Information, Hemostatic Agents in Endoscopy Manufacturing Base, Sales Area and Its Competitors
Table 92. Medtronic Hemostatic Agents in Endoscopy Product Portfolios and Specifications
Table 93. Medtronic Hemostatic Agents in Endoscopy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Medtronic Main Business
Table 95. Medtronic Latest Developments
Table 96. EndoClot Plus Basic Information, Hemostatic Agents in Endoscopy Manufacturing Base, Sales Area and Its Competitors
Table 97. EndoClot Plus Hemostatic Agents in Endoscopy Product Portfolios and Specifications
Table 98. EndoClot Plus Hemostatic Agents in Endoscopy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. EndoClot Plus Main Business
Table 100. EndoClot Plus Latest Developments
Table 101. Ankaferd Health Products Basic Information, Hemostatic Agents in Endoscopy Manufacturing Base, Sales Area and Its Competitors
Table 102. Ankaferd Health Products Hemostatic Agents in Endoscopy Product Portfolios and Specifications
Table 103. Ankaferd Health Products Hemostatic Agents in Endoscopy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Ankaferd Health Products Main Business
Table 105. Ankaferd Health Products Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hemostatic Agents in Endoscopy
Figure 2. Hemostatic Agents in Endoscopy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemostatic Agents in Endoscopy Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Hemostatic Agents in Endoscopy Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Hemostatic Agents in Endoscopy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Hemostatic Agents in Endoscopy Sales Market Share by Country/Region (2025)
Figure 10. Hemostatic Agents in Endoscopy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peptide Hydrogels
Figure 12. Product Picture of Mineral Hemostatic Powder
Figure 13. Product Picture of Other
Figure 14. Global Hemostatic Agents in Endoscopy Sales Market Share by Type in 2026
Figure 15. Global Hemostatic Agents in Endoscopy Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Self-assembling Type
Figure 17. Product Picture of Spray Type
Figure 18. Product Picture of Other
Figure 19. Global Hemostatic Agents in Endoscopy Sales Market Share by Product in 2026
Figure 20. Global Hemostatic Agents in Endoscopy Revenue Market Share by Product (2021-2026)
Figure 21. Hemostatic Agents in Endoscopy Consumed in ESD
Figure 22. Global Hemostatic Agents in Endoscopy Market: ESD (2021-2026) & (K Units)
Figure 23. Hemostatic Agents in Endoscopy Consumed in EMR
Figure 24. Global Hemostatic Agents in Endoscopy Market: EMR (2021-2026) & (K Units)
Figure 25. Hemostatic Agents in Endoscopy Consumed in Other
Figure 26. Global Hemostatic Agents in Endoscopy Market: Other (2021-2026) & (K Units)
Figure 27. Global Hemostatic Agents in Endoscopy Sale Market Share by Application (2025)
Figure 28. Global Hemostatic Agents in Endoscopy Revenue Market Share by Application in 2025
Figure 29. Hemostatic Agents in Endoscopy Sales by Company in 2025 (K Units)
Figure 30. Global Hemostatic Agents in Endoscopy Sales Market Share by Company in 2025
Figure 31. Hemostatic Agents in Endoscopy Revenue by Company in 2025 ($ millions)
Figure 32. Global Hemostatic Agents in Endoscopy Revenue Market Share by Company in 2025
Figure 33. Global Hemostatic Agents in Endoscopy Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global Hemostatic Agents in Endoscopy Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Hemostatic Agents in Endoscopy Sales 2021-2026 (K Units)
Figure 36. Americas Hemostatic Agents in Endoscopy Revenue 2021-2026 ($ millions)
Figure 37. APAC Hemostatic Agents in Endoscopy Sales 2021-2026 (K Units)
Figure 38. APAC Hemostatic Agents in Endoscopy Revenue 2021-2026 ($ millions)
Figure 39. Europe Hemostatic Agents in Endoscopy Sales 2021-2026 (K Units)
Figure 40. Europe Hemostatic Agents in Endoscopy Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa Hemostatic Agents in Endoscopy Sales 2021-2026 (K Units)
Figure 42. Middle East & Africa Hemostatic Agents in Endoscopy Revenue 2021-2026 ($ millions)
Figure 43. Americas Hemostatic Agents in Endoscopy Sales Market Share by Country in 2025
Figure 44. Americas Hemostatic Agents in Endoscopy Revenue Market Share by Country (2021-2026)
Figure 45. Americas Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
Figure 46. Americas Hemostatic Agents in Endoscopy Sales Market Share by Application (2021-2026)
Figure 47. United States Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC Hemostatic Agents in Endoscopy Sales Market Share by Region in 2025
Figure 52. APAC Hemostatic Agents in Endoscopy Revenue Market Share by Region (2021-2026)
Figure 53. APAC Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
Figure 54. APAC Hemostatic Agents in Endoscopy Sales Market Share by Application (2021-2026)
Figure 55. China Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 59. India Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe Hemostatic Agents in Endoscopy Sales Market Share by Country in 2025
Figure 63. Europe Hemostatic Agents in Endoscopy Revenue Market Share by Country (2021-2026)
Figure 64. Europe Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
Figure 65. Europe Hemostatic Agents in Endoscopy Sales Market Share by Application (2021-2026)
Figure 66. Germany Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 67. France Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 68. UK Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa Hemostatic Agents in Endoscopy Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa Hemostatic Agents in Endoscopy Sales Market Share by Application (2021-2026)
Figure 74. Egypt Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Hemostatic Agents in Endoscopy in 2026
Figure 80. Manufacturing Process Analysis of Hemostatic Agents in Endoscopy
Figure 81. Industry Chain Structure of Hemostatic Agents in Endoscopy
Figure 82. Channels of Distribution
Figure 83. Global Hemostatic Agents in Endoscopy Sales Market Forecast by Region (2027-2032)
Figure 84. Global Hemostatic Agents in Endoscopy Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global Hemostatic Agents in Endoscopy Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global Hemostatic Agents in Endoscopy Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global Hemostatic Agents in Endoscopy Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global Hemostatic Agents in Endoscopy Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Hemostatic Agents in Endoscopy
Figure 2. Hemostatic Agents in Endoscopy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemostatic Agents in Endoscopy Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Hemostatic Agents in Endoscopy Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Hemostatic Agents in Endoscopy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Hemostatic Agents in Endoscopy Sales Market Share by Country/Region (2025)
Figure 10. Hemostatic Agents in Endoscopy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peptide Hydrogels
Figure 12. Product Picture of Mineral Hemostatic Powder
Figure 13. Product Picture of Other
Figure 14. Global Hemostatic Agents in Endoscopy Sales Market Share by Type in 2026
Figure 15. Global Hemostatic Agents in Endoscopy Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Self-assembling Type
Figure 17. Product Picture of Spray Type
Figure 18. Product Picture of Other
Figure 19. Global Hemostatic Agents in Endoscopy Sales Market Share by Product in 2026
Figure 20. Global Hemostatic Agents in Endoscopy Revenue Market Share by Product (2021-2026)
Figure 21. Hemostatic Agents in Endoscopy Consumed in ESD
Figure 22. Global Hemostatic Agents in Endoscopy Market: ESD (2021-2026) & (K Units)
Figure 23. Hemostatic Agents in Endoscopy Consumed in EMR
Figure 24. Global Hemostatic Agents in Endoscopy Market: EMR (2021-2026) & (K Units)
Figure 25. Hemostatic Agents in Endoscopy Consumed in Other
Figure 26. Global Hemostatic Agents in Endoscopy Market: Other (2021-2026) & (K Units)
Figure 27. Global Hemostatic Agents in Endoscopy Sale Market Share by Application (2025)
Figure 28. Global Hemostatic Agents in Endoscopy Revenue Market Share by Application in 2025
Figure 29. Hemostatic Agents in Endoscopy Sales by Company in 2025 (K Units)
Figure 30. Global Hemostatic Agents in Endoscopy Sales Market Share by Company in 2025
Figure 31. Hemostatic Agents in Endoscopy Revenue by Company in 2025 ($ millions)
Figure 32. Global Hemostatic Agents in Endoscopy Revenue Market Share by Company in 2025
Figure 33. Global Hemostatic Agents in Endoscopy Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global Hemostatic Agents in Endoscopy Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Hemostatic Agents in Endoscopy Sales 2021-2026 (K Units)
Figure 36. Americas Hemostatic Agents in Endoscopy Revenue 2021-2026 ($ millions)
Figure 37. APAC Hemostatic Agents in Endoscopy Sales 2021-2026 (K Units)
Figure 38. APAC Hemostatic Agents in Endoscopy Revenue 2021-2026 ($ millions)
Figure 39. Europe Hemostatic Agents in Endoscopy Sales 2021-2026 (K Units)
Figure 40. Europe Hemostatic Agents in Endoscopy Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa Hemostatic Agents in Endoscopy Sales 2021-2026 (K Units)
Figure 42. Middle East & Africa Hemostatic Agents in Endoscopy Revenue 2021-2026 ($ millions)
Figure 43. Americas Hemostatic Agents in Endoscopy Sales Market Share by Country in 2025
Figure 44. Americas Hemostatic Agents in Endoscopy Revenue Market Share by Country (2021-2026)
Figure 45. Americas Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
Figure 46. Americas Hemostatic Agents in Endoscopy Sales Market Share by Application (2021-2026)
Figure 47. United States Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC Hemostatic Agents in Endoscopy Sales Market Share by Region in 2025
Figure 52. APAC Hemostatic Agents in Endoscopy Revenue Market Share by Region (2021-2026)
Figure 53. APAC Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
Figure 54. APAC Hemostatic Agents in Endoscopy Sales Market Share by Application (2021-2026)
Figure 55. China Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 59. India Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe Hemostatic Agents in Endoscopy Sales Market Share by Country in 2025
Figure 63. Europe Hemostatic Agents in Endoscopy Revenue Market Share by Country (2021-2026)
Figure 64. Europe Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
Figure 65. Europe Hemostatic Agents in Endoscopy Sales Market Share by Application (2021-2026)
Figure 66. Germany Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 67. France Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 68. UK Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa Hemostatic Agents in Endoscopy Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa Hemostatic Agents in Endoscopy Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa Hemostatic Agents in Endoscopy Sales Market Share by Application (2021-2026)
Figure 74. Egypt Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries Hemostatic Agents in Endoscopy Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Hemostatic Agents in Endoscopy in 2026
Figure 80. Manufacturing Process Analysis of Hemostatic Agents in Endoscopy
Figure 81. Industry Chain Structure of Hemostatic Agents in Endoscopy
Figure 82. Channels of Distribution
Figure 83. Global Hemostatic Agents in Endoscopy Sales Market Forecast by Region (2027-2032)
Figure 84. Global Hemostatic Agents in Endoscopy Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global Hemostatic Agents in Endoscopy Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global Hemostatic Agents in Endoscopy Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global Hemostatic Agents in Endoscopy Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global Hemostatic Agents in Endoscopy Revenue Market Share Forecast by Application (2027-2032)
